Big Pharma Set to Hit Sales Cliff as Demand for COVID Vaccine Is Set to Plummet in 2023

Big Pharma Set to Hit Sales Cliff as Demand for COVID Vaccine Is Set to Plummet in 2023
Pfizer BioNTech and Moderna COVID-19 vaccines. Shutterstock
|Updated:
0:00

Big Pharma is facing a reckoning as they face a sales cliff with demand for the COVID vaccine projected to plummet by the end of the year.

The world’s largest pharmaceutical companies have raked in billions from the COVID-19 pandemic over the past two years, after governments around the world mandated vaccines for their populations.

Bryan Jung
Bryan Jung
Author
Bryan S. Jung is a native and resident of New York City with a background in politics and the legal industry. He graduated from Binghamton University.
Related Topics